Related Experiment Video

Updated: May 18, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis

Yan Wang1, Haiquan Jia, Huiyun Lin

  • 1Department of Advanced Interdisciplinary Studies, Institute of Basic Medical Sciences, Beijing, China. yan_way@yahoo.com.cn

Journal of Cellular and Molecular Medicine
|September 19, 2012
PubMed

Insights

Metastasis-associated gene 1 (mag-1) promotes cancer cell invasion and metastasis by stabilizing HIF-1α and activating mTOR signaling. Inhibiting mag-1 reduces tumor growth and spread, offering new anti-metastatic therapy targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is a primary cause of cancer mortality, with poorly understood mechanisms.
  • Identifying novel metastasis regulators is crucial for developing effective anti-metastatic therapies.

Purpose of the Study:

  • To investigate the role of metastasis-associated gene 1 (mag-1) in cancer metastasis.
  • To elucidate the molecular mechanisms by which mag-1 promotes tumor invasion and metastasis.

Main Methods:

  • Metastatic phenotype cloning to identify mag-1.
  • In vitro assays for cell migration, adhesion, and invasion.
  • In vivo spontaneous metastatic assays in mice.
  • RNA interference to disrupt mag-1 expression.
  • Analysis of HIF-1α stabilization and mTOR signaling pathway activation.

Main Results:

  • Mag-1 overexpression promoted in vitro cell migration, adhesion, and invasion.
  • Mag-1 disruption via RNA interference inhibited cellular metastatic behaviors.
  • Mag-1 inhibition significantly reduced tumor weight and lung metastasis in vivo.
  • Mag-1 stabilizes HIF-1α and activates the mTOR signaling pathway.
  • Rapamycin, an mTOR inhibitor, abrogated mag-1-induced metastatic promotion.

Conclusions:

  • Mag-1 plays a direct role in promoting cancer metastasis.
  • Mag-1 functions by stabilizing HIF-1α and activating mTOR signaling.
  • Mag-1 is implicated in cellular adaptation to the tumor microenvironment.
  • Mag-1 represents a potential therapeutic target for anti-metastatic strategies.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...